Waterfront Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Waterfront Wealth's PFE Position: Q2 2026 in Review
Waterfront Wealth increased its Pfizer (PFE) stake by 0.51% in Q2 2026, buying an estimated $2.17K and bringing the position to 16,362 shares worth $395K. The position accounts for 0.06% of the portfolio, ranked #232.
Waterfront Wealth first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $707K in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Waterfront Wealth held 16,362 shares of Pfizer worth $395K as of Q2 2026.
- Waterfront Wealth bought 83 Pfizer shares in Q2 2026, an estimated $2.17K.
- Pfizer made up 0.06% of Waterfront Wealth's portfolio in Q2 2026, its #232 holding.
- Waterfront Wealth first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- Waterfront Wealth's Pfizer position peaked at $707K in Q4 2021.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.